|Articles|December 2, 2001

Pharmaceutical Technology

  • Pharmaceutical Technology-12-02-2001
  • Volume 25
  • Issue 12

Bioterrorism Threat Shines Spotlight on Drug Manufacturing

Author(s)Jill Wechsler

Anthrax contamination has put pharmaceutical quality and supply issues on the front page, along with patent and pricing policies.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.